Catheter closure of atrial septal defects using the Cocoon septal occluder: Preliminary results of a European multicenter study

Thanopoulos, Basil D.; Biasco, Luigi; Dardas, Petros S.; Avraamides, Panayiotis; Deleanou, Dan; Ninios, Vlassis; Mavrommatis, Petros P.; Soendergaard, Lars

doi:10.1016/j.ijcard.2014.09.006

Cited by 13 publications

(14 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There are 17 device options ranging from 8 to 40 mm with 2-mm increments and the delivery sheath sizes range from 7 to 14 Fr. European multicenter study reported an excellent result with procedural success rate of 100% and no complication in 92 patients (49). This device has been described as softest and lightest currently available device with less metal-to-septum ratio than other devices (49).…”

Section: Cocoon Septal Occluder (Figure 7e)mentioning

confidence: 91%

“…European multicenter study reported an excellent result with procedural success rate of 100% and no complication in 92 patients (49). This device has been described as softest and lightest currently available device with less metal-to-septum ratio than other devices (49). The disadvantages are its relatively limited size options (17 vs. 27 sizes in ASO) and the requirement of a slightly larger delivery sheath than with ASO devices.…”

Section: Cocoon Septal Occluder (Figure 7e)mentioning

confidence: 97%

See 1 more Smart Citation

Transcatheter closure of atrial septal defect: principles and available devices

Jung¹,

Choi²

2018

J. Thorac. Dis.

View full text Add to dashboard Cite

There has been a remarkable improvement in the treatment strategy of secundum atrial septal defect (ASD) over the last few decades. Indebted to the improvement in device technology and procedural techniques, transcatheter closure of ASD is currently accepted as the treatment of choice in most patients with secundum ASD. Recent generation devices enable easy and safe deployment of device with the properties of adequate flexibility, re-capturability and repositioning. Use of biocompatible materials with improved device design and refined equipment finish may promote re-endothelialization and reduce potential damage to nearby structures. Most of currently available devices show excellent efficacy and comparable outcome with its own advantages and disadvantages. In addition to improvement of device properties and performance, there has been distinct improvement in procedural technique from numerous experiences of device closure of ASD. Nowadays there are well established principles regarding patient selection, pre-procedural evaluation, step-by-step details of procedure as well as post-procedural follow-up. However, an operator may encounter pitfalls in closing complex lesions such as large defect, rim deficiencies and multiple defects, so every operator has to be familiar with each available device, general principle as well as special issues for complex lesions.

show abstract

Section: Cocoon Septal Occluder (Figure 7e)mentioning

confidence: 91%

Section: Cocoon Septal Occluder (Figure 7e)mentioning

confidence: 97%

Transcatheter closure of atrial septal defect: principles and available devices

Jung¹,

Choi²

2018

J. Thorac. Dis.

View full text Add to dashboard Cite

show abstract

“…Recently, percutaneous device closure has been the preferred choice in the treatment of the secundum ASDs with various devices in patients with sufficient rims [1,2,5,10,11]. Despite the significant refinement in device technology, there is no ideal device that closes all of the secundum ASDs without significant complications either in early and immediate term or in the long term.…”

Section: Discussionmentioning

confidence: 99%

“…The procedure is feasible and effective, even in patients with complex ASDs [1][2][3][4]. However, the procedure is not free of complications and problems with the current devices [5]. Early-or late-occurring device-related cardiac rupture and tamponade have been among the most feared complications [6][7][8].…”

Section: Introductionmentioning

confidence: 99%

Initial Experience with the Nit-Occlud ASD-R: Short-Term Results

et al. 2016

View full text Add to dashboard Cite

We aim to assess the safety, feasibility and efficacy of the new Nit-Occlud ASD-R (NOASD-R) device. From 2014 to 2015, transcatheter closure of atrial septal defect (ASD) using the NOASD-R was performed in 30 consecutive patients. The standard deployment technique as the left upper pulmonary vein approach was used in 25 patients. Right upper pulmonary vein approach was required in five. The median age was 6 years (range 3.5-60 years), and median weight was 21.5 kg (14-79 kg). Implantation was successful in all patients. The median size of devices was 16 mm (12.0-26.0 mm). The mean device size/2D defect diameter ratio was 1.26 ± 0.09 (1.12-1.40). The mean device size/color flow diameter ratio was 1.07 ± 0.06 (range 1.0-1.22). Releasing problem was encountered in three patients. A device-related erosion on the day after the closure was observed in one patient. No further device-related complication (erosion, embolization or dislodgement of the device) was encountered in a median follow-up period of 10 months (range 2-14 months). Complete occlusion has occurred in all at follow-up. NOASD-R is a feasible and effective device for use in the transcatheter occlusion of moderate to large secundum ASDs in selected patients. The occurrence of the erosion on the right atrial roof may be due to the high localization of the device and the larger size of the right disk.

show abstract

“…Most of currently available devices show excellent closure efficacy and quite comparable outcomes; however, they have their own advantages and disadvantages. [71][72][73][74][75][76][77][78][79][80] There have been a couple of ASD closure devices available on the Polish market over the past years (TABLE 2; see Supplementary material for a detailed description).…”

Section: Short Review Of the Devices Available Inmentioning

confidence: 99%

Percutaneous closure of atrial septal defect: a consensus document of the joint group of experts from the Association of Cardiovascular Interventions and the Grown-Up Congenital Heart Disease Section of the Polish Cardiac Society

et al. 2020

View full text Add to dashboard Cite

communication. There are 5 types of anatomic defects known: • Secundum ASD (ASD II): 80% to even more than 90% of ASDs in the adult population; located in the fossa ovalis region and its surrounding tissue. Background information on atrial septal defect Atrial septal defect (ASD) is one of the most prevalent congenital heart defects and may frequently remain undiagnosed until adulthood. 1-4 It is a consequence of various embryological disorders that cause interatrial

show abstract

Catheter closure of atrial septal defects using the Cocoon septal occluder: Preliminary results of a European multicenter study

Cited by 13 publications

References 14 publications

Transcatheter closure of atrial septal defect: principles and available devices

Transcatheter closure of atrial septal defect: principles and available devices

Initial Experience with the Nit-Occlud ASD-R: Short-Term Results

Percutaneous closure of atrial septal defect: a consensus document of the joint group of experts from the Association of Cardiovascular Interventions and the Grown-Up Congenital Heart Disease Section of the Polish Cardiac Society

Contact Info

Product

Resources

About